1. Phenanthridine Derivatives as Potential HIV-1 Protease Inhibitors. Ershov, P.V., Y.V. Мezentsev, L.A. Kaluzhskiy, and A.S. Ivanov. Biomedical Reports, 2020. 13(6): 66. PMID[33149910]. PMCID[PMC7605122].
[PubMed]. HIV_12_2020.
2. Identification and Tracking of Antiviral Drug Combinations. Ianevski, A., R.A. Yao, S. Biza, E. Zusinaite, A. Mannik, G. Kivi, A. Planken, K. Kurg, E.M. Tombak, M. Ustav, N. Shtaida, E. Kulesskiy, E. Jo, J. Yang, H. Lysvand, K. Loseth, V. Oksenych, P.A. Aas, T. Tenson, A. Vitkauskiene, M.P. Windisch, M.H. Fenstad, S.A. Nordbo, M. Ustav, M. Bjoras, and D.E. Kainov. Viruses, 2020. 12(10): 1178. ISI[000587455300001].
[WOS]. HIV_12_2020.
3. Curcumin as an Antiviral Agent. Jennings, M.R. and R.J. Parks. Viruses, 2020. 12(11): 1242. PMID[33142686]. PMCID[PMC7693600].
[PubMed]. HIV_12_2020.
4. Primary HIV-1 and Infectious Molecular Clones Are Differentially Susceptible to Broadly Neutralizing Antibodies. Kim, J., V.B. Rao, and M. Rao. Vaccines, 2020. 8(4): 782. PMID[33371189]. PMCID[PMC7767270].
[PubMed]. HIV_12_2020.
5. Bivalent HIV-1 Fusion Inhibitors Based on Peptidomimetics. Kobayakawa, T., K. Ebihara, K. Tsuji, T. Kawada, M. Fujino, Y. Honda, N. Ohashi, T. Murakami, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2020. 28(24): 115812. PMID[33157478].
[PubMed]. HIV_12_2020.
6. Maraviroc Reactivates HIV with Potency Similar to That of Other Latency Reversing Drugs without Inducing Toxicity in CD8 T Cells. López-Huertas, M.R., L. Jiménez-Tormo, N. Madrid-Elena, C. Gutiérrez, M.J. Vivancos, L. Luna, and S. Moreno. Biochemical Pharmacology, 2020. 182: 114231. PMID[32979351].
[PubMed]. HIV_12_2020.
7. Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry. Ma, H.G., H.Q. Wang, M.C. Li, V. Barreto-de-Souza, B.A. Reinecke, R. Gunta, Y. Zheng, G.F. Kang, N. Nassehi, H.J. Zhang, J. An, D.E. Selley, K.F. Hauser, and Y. Zhang. ACS Medicinal Chemistry Letters, 2020. 11(11): p. 2318-2324. PMID[33214847]. PMCID[PMC7667867].
[PubMed]. HIV_12_2020.
8. Synthesis of Fused Oxepane HIV Integrase Inhibitor MK-1376. Maligres, P.E., Z.J. Song, N.A. Strotman, J.Q. Yin, T. Pei, H.R. Strotman, T. Itoh, E.C. Sherer, and G.R. Humphrey. Synthesis, 2020. 52(22): p. 3378-3388. ISI[000580552800006].
[WOS]. HIV_12_2020.
9. New Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors Show Low Nanomolar Inhibition of Single and Double HIV-1 Mutant Strains. Nalli, M., J.I. Armijos Rivera, D. Masci, A. Coluccia, R. Badia, E. Riveira-Muñoz, A. Brambilla, E. Cinquina, O. Turriziani, F. Falasca, M. Catalano, C. Limatola, J.A. Esté, G. Maga, R. Silvestri, E. Crespan, and G. La Regina. European Journal of Medicinal Chemistry, 2020. 208: 112696. PMID[32883642].
[PubMed]. HIV_12_2020.
10. Anti-HIV Tigliane Diterpenoids from Wikstroemia scytophylla. Otsuki, K., M. Zhang, A. Yamamoto, M. Tsuji, M. Tejima, Z.S. Bai, D. Zhou, L. Huang, C.H. Chen, K.H. Lee, N. Li, W. Li, and K. Koike. Journal of Natural Products, 2020. 83(12): p. 3584-3590. PMID[33172265].
[PubMed]. HIV_12_2020.
11. A Strain-specific Inhibitor of Receptor-bound HIV-1 Targets a Pocket near the Fusion Peptide. Ozorowski, G. J.L. Torres, D. Santos-Martins, S. Forli, and A.B. Ward. Cell Reports, 2020. 33(8): 108428. PMID[33238117]. PMCID[PMC7701285].
[PubMed]. HIV_12_2020.
12. Paliasanines A-E, 3,4-Methylenedioxyquinoline Alkaloids Fused with a Phenyl-14-Oxabicyclo 3.2.1 octane Unit from Melochia umbellata var. Deglabrata. Rahim, A., Y. Saito, S. Fukuyoshi, K. Miyake, M. Goto, C.H. Chen, G. Alam, K.H. Lee, and K. Nakagawa-Goto. Journal of Natural Products, 2020. 83(10): p. 2931-2939. PMID[32946697].
[PubMed]. HIV_12_2020.
13. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, anti-HIV-1 and Integrase Inhibitory Assay. Safakish, M., Z. Hajimahdi, R. Vahabpour, R. Zabihollahi, and A. Zarghi. Medicinal Chemistry, 2020. 16(7): p. 938-946. PMID[31448713].
[PubMed]. HIV_12_2020.
14. Alkylated Benzimidazoles: Design, Synthesis, Docking, Dft Analysis, ADMET Property, Molecular Dynamics and Activity against HIV and YFV. Srivastava, R., S.K. Gupta, F. Naaz, P.S. Sen Gupta, M. Yadav, V.K. Singh, A. Singh, M.K. Rana, S.K. Gupta, D. Schols, and R.K. Singh. Computational Biology and Chemistry, 2020. 89: 107400. PMID[33068917]. PMCID[PMC7537607].
[PubMed]. HIV_12_2020.
15. Nef Homodimers Down-regulate SERINC5 by AP-2-mediated Endocytosis to Promote HIV-1 Infectivity. Staudt, R.P. and T.E. Smithgall. Journal of Biological Chemistry, 2020. 295(46): p. 15540-15552. PMID[32873704]. PMCID[PMC7667984].
[PubMed]. HIV_12_2020.
16. Harmine Enhances the Activity of the HIV-1 Latency-reversing Agents Ingenol A and SAHA. Taylor, J.P., L.H. Armitage, D.L. Aldridge, M.N. Cash, and M.A. Wallet. Biology Open, 2020. 9(12): bio052969. PMID[33234703]. PMCID[PMC7774897].
[PubMed]. HIV_12_2020.
17. Scaffold Hopping and Optimisation of 3',4'-dihydroxyphenyl- Containing Thienopyrimidinones: Synthesis of Quinazolinone Derivatives as Novel Allosteric Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H. Tocco, G., F. Esposito, P. Caboni, A. Laus, J.A. Beutler, J.A. Wilson, A. Corona, S.F.J. Le Grice, and E. Tramontano. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020. 35(1): p. 1953-1963. PMID[33143469]. PMCID[PMC7646544].
[PubMed]. HIV_12_2020.
18. Novel Monomolecular Derivatives of the anti-HIV-1 G-quadruplex-forming Hotoda's Aptamer Containing Inversion of Polarity Sites. Virgilio, A., V. Esposito, M. Tassinari, M. Nadai, S.N. Richter, and A. Galeone. European Journal of Medicinal Chemistry, 2020. 208: 112786. PMID[32911256].
[PubMed]. HIV_12_2020.
19. Structure-Activity Relationship, Molecular Docking, and Molecular Dynamic Studies of Diterpenes from Marine Natural Products with anti-HIV Activity. von Ranke, N.L., M.M.J. Ribeiro, L.A. Miceli, N.P. de Souza, B.A. Abrahim-Vieira, H.C. Castro, V.L. Teixeira, C.R. Rodrigues, and A.M.T. Souza. Journal of Biomolecular Structure & Dynamics, 2020. 2020: 1-11. PMID[33183161].
[PubMed]. HIV_12_2020.
20. Novel Betulinic acid-nucleoside Hybrids with Potent anti-HIV Activity. Wang, Q., Y.J. Li, L.Y. Zheng, X.W. Huang, Y.L. Wang, C.H. Chen, Y.Y. Cheng, S.L. Morris-Natschke, and K.H. Lee. ACS Medicinal Chemistry Letters, 2020. 11(11): p. 2290-2293. PMID[33214842]. PMCID[PMC7667853].
[PubMed]. HIV_12_2020.
21. Targeting Dual Tolerant Regions of Binding Pocket: Discovery of Novel Morpholine-Substituted Diarylpyrimidines as Potent HIV-1 NNRTIs with Significantly Improved Water Solubility. Wang, Z., D.W. Kang, D. Feng, S. Cherukupalli, X.Y. Jiang, Z.P. Fu, E. De Clercq, C. Pannecouque, X.Y. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2020. 206: 112811. PMID[32977301].
[PubMed]. HIV_12_2020.
22. Epigenetic Compound Screening Uncovers Small Molecules for Reactivation of Latent HIV-1. Zutz, A., L. Chen, F. Sippl, A. Humpe, and C. Schölz. Antimicrobial Agents and Chemotherapy, 2020. 65(1): e01815-20. PMID[33139279].
[PubMed]. HIV_12_2020.
Patent Citations
23. Pyridinone Derivatives as Selective Cytotoxic Agents against HIV Infected Cells and Their Preparation. Converso, A., A. El Marrouni, A. Forster, J.L. Frie, D.N. Hunter, C. Wang, and D. Wang. Patent. 2020. 2020-US33358 2020236692: 111pp.
[Patent]. HIV_12_2020.